NCT00468260终止1 期
An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies-extension Study
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- Safety
研究概览
简要总结
To evaluate the effects of patupilone on the pharmacokinetics of warfarin in patients with advanced malignancies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Safety
Tolerability
Potential activity of patupilone once every 21 days in patients that completed the core study
次要结局
- Objective response and tumor evaluation assessed by response evaluation criteria in solid tumors (RECIST)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced MalignanciesAdvanced MalignanciesNCT00448396Novartis Pharmaceuticals17
已完成
1 期
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced MalignanciesTumorsNCT00420524Novartis Pharmaceuticals36
已完成
2 期
Patupilone Activity in Advanced/Metastatic Hepatocellular CarcinomaHepatocellular CarcinomaNCT00273312Novartis Pharmaceuticals25
已完成
2 期
Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung CancerBrain MetastasisNon-small Cell Lung CancerNCT00219297Novartis Pharmaceuticals50
撤回
1 期
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)Solid TumorsNCT00442741Novartis Pharmaceuticals